MedPath

成都天之翼尚品医药科技有限公司

Ownership
-
Established
2011-07-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Lidocaine and Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20253517
Approval Date
Mar 4, 2025
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20249073
Approval Date
Oct 16, 2024
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20249072
Approval Date
Oct 16, 2024
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H20247202
Approval Date
Sep 5, 2024
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20244540
Approval Date
Jul 30, 2024
NMPA

Ampicillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用氨苄西林钠舒巴坦钠
Approval Number
国药准字H20244213
Approval Date
Jun 28, 2024
NMPA

Ampicillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用氨苄西林钠舒巴坦钠
Approval Number
国药准字H20244214
Approval Date
Jun 28, 2024
NMPA

Ampicillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用氨苄西林钠舒巴坦钠
Approval Number
国药准字H20244212
Approval Date
Jun 28, 2024
NMPA

Benzylpenicillin Sodium for Injection

Product Name
注射用青霉素钠
Approval Number
国药准字H20243789
Approval Date
May 21, 2024
NMPA

Benzylpenicillin Sodium for Injection

Product Name
注射用青霉素钠
Approval Number
国药准字H20243791
Approval Date
May 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath